AnnouncedFiled 7 January 2025
NewLimit, Inc. has sold $72.2M so far
NewLimit, Inc., a biotech company based in South San Francisco, CA, has sold $72.2M so far in its equity round, according to a filing dated 7 January 2025.
Announced on 16 May 2023, 602 days before the filing. blog.newlimit.com ↗
- Filed
- 7 January 2025
- First filed
- 17 May 2023
- Round
- Equity round (amended filing)
- Amount sold
- $72.2M
- Offering size
- $72.2M
- Investors so far
- 21
- Based in
- South San Francisco, CA
- Website
- newlimit.com
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 92% of the 1,404 tracked raises with an amount filed in 2025, and than 86% of the 112 in biotech.
NewLimit, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 15 May 2025 | New filing | $130M | Another raise |
| 7 Jan 2025 | Amended filing | $72.2M | This raise |
| 17 May 2023 | New filing | $60M | This raise |
More with Curiosity Group Opportunity One on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.